Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
Published July 9, 2014 · Recall initiated: June 19, 2014
Summary
FDA records drug Class II recall D-1412-2014, published July 9, 2014 and initiated June 19, 2014. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 92,544 Bottles; Lot: Lot # A308879, Expiry: 09/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Drug failed stage III dissolution testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Forest Pharmaceuticals Inc
- Distributor
- Nationwide including Puerto Rico.
- Lot
- Lot # A308879, Expiry: 09/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays,October 29, 2014
- FDABrevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mLJuly 9, 2014
- FDAMAS Omni Immune PRO ControlsJuly 2, 2014
- FDABystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc.,May 28, 2014
- FDANamenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest PharmaceuticalsFebruary 12, 2014
- FDANamenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs,February 12, 2014
Questions about this recall
Was Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07. recalled?
Yes. FDA published recall D-1412-2014 on July 9, 2014. Reported hazard: Failed Dissolution Specifications: Drug failed stage III dissolution testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter